Anson Funds Management LP - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C121. A total of 5 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Anson Funds Management LP ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q3 2018$255,000
-39.4%
218,0230.0%0.09%
-63.2%
Q2 2018$421,000
-41.1%
218,023
-1.9%
0.25%
-53.7%
Q1 2018$715,000–222,173–0.53%–
 Download
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q3 2018
NameSharesValueWeighting ↓
Anson Funds Management LP 222,173$715,0000.53%
CVI Holdings, LLC 221,686$100,0000.14%
SABBY MANAGEMENT, LLC 393,044$176,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3,000$1,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders